País: Suïssa
Idioma: alemany
Font: Swissmedic (Swiss Agency for Therapeutic Products)
mometasoni-17 furoas
Helvepharm AG
R01AD09
mometasoni-17 furoas
Fahrwerk
mometasoni-17 furoas 0.5 mg ut mometasoni-17 furoas monohydricus, benzalkonii chloridum 0.2 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140.
B
Synthetika
Rhinitis, Nasenpolypen
zugelassen
2022-07-09